Nabla's $70 Million Leap: Transforming Clinical Care with Agentic AI
June 18, 2025, 3:33 am
Nabla is on a mission. With a fresh $70 million in Series C funding, the New York City-based company is poised to revolutionize clinical workflows. This funding round, led by HV Capital, with support from Highland Europe, DST Global, and existing investors, brings Nabla's total capital to $120 million. The goal? To create an "agentic" AI assistant that not only documents care but actively enhances it.
Nabla's AI assistant is not just another tool in the clinician's toolbox. It’s a game-changer. The company’s technology is already embedded in over 130 healthcare organizations, including major academic medical centers and community health systems. The assistant helps clinicians generate notes in seconds, integrating seamlessly with electronic health records (EHRs) and supporting more than 35 languages. This is not just about speed; it’s about accuracy and efficiency.
The new funding will accelerate product development and expand Nabla's reach into new care settings. The company aims to enhance clinical documentation integrity (CDI) and adapt its AI capabilities to support diverse clinical roles. Imagine a world where AI not only listens but understands. A world where it can initiate EHR actions and streamline workflows. That’s the vision Nabla is chasing.
The healthcare landscape is changing rapidly. Clinicians are overwhelmed. Burnout is rampant. Nabla’s AI assistant addresses these issues head-on. By cutting documentation time by more than half, it allows clinicians to focus on what truly matters: patient care. Studies from the University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a notable increase in patient satisfaction.
Nabla’s growth trajectory is impressive. In just six months, the company has multiplied its revenue fivefold. It now supports over 85,000 clinicians and facilitates 20 million annual encounters. This rapid adoption is a testament to the platform's effectiveness. It’s not just about numbers; it’s about impact. The assistant is designed to serve a broad range of care environments, from rural hospitals to children’s hospitals, where operational efficiency is critical.
The upcoming features of Nabla’s Adaptive Agentic Platform are exciting. A proactive coding agent will enhance real-time support for coding practices, ensuring compliance and accuracy. A context-aware agent will leverage historical data to improve documentation and initiate orders. This is not just an upgrade; it’s a transformation. The platform is evolving into a comprehensive solution that anticipates the needs of clinicians.
Nabla’s commitment to customization is noteworthy. The platform is built to adapt to various specialties and care settings. This flexibility is crucial in a field where one size does not fit all. The company’s focus on clinician experience and enterprise readiness sets it apart. Health systems report high adoption rates and streamlined onboarding processes. Nabla listens to its partners, adapting its technology based on real-time feedback. This collaborative approach fosters trust and drives meaningful change.
The healthcare industry is at a crossroads. As technology advances, the need for intelligent solutions becomes more pressing. Nabla stands out as a pioneer in clinical AI. Its ability to combine technological excellence with empathy for clinicians is remarkable. The company is not just building a product; it’s shaping the future of healthcare.
Nabla’s journey is just beginning. With the new funding, the company is set to deepen its integration into clinical workflows. The vision is clear: a proactive assistant that enhances care delivery. This is not just about efficiency; it’s about improving the clinician-patient relationship. By reducing administrative burdens, Nabla allows healthcare providers to spend more time with their patients.
The road ahead is filled with opportunities. As Nabla expands its capabilities, it will continue to address the pressing challenges in healthcare. The focus on clinician burnout and patient satisfaction is more relevant than ever. In a world where time is a precious commodity, Nabla’s AI assistant is a beacon of hope.
In conclusion, Nabla’s $70 million funding round is more than just a financial milestone. It’s a signal of the changing tides in healthcare. The company is poised to lead the charge in transforming clinical workflows through intelligent AI solutions. As it continues to innovate, the impact on clinicians and patients alike will be profound. The future of healthcare is here, and Nabla is at the forefront.
Nabla's AI assistant is not just another tool in the clinician's toolbox. It’s a game-changer. The company’s technology is already embedded in over 130 healthcare organizations, including major academic medical centers and community health systems. The assistant helps clinicians generate notes in seconds, integrating seamlessly with electronic health records (EHRs) and supporting more than 35 languages. This is not just about speed; it’s about accuracy and efficiency.
The new funding will accelerate product development and expand Nabla's reach into new care settings. The company aims to enhance clinical documentation integrity (CDI) and adapt its AI capabilities to support diverse clinical roles. Imagine a world where AI not only listens but understands. A world where it can initiate EHR actions and streamline workflows. That’s the vision Nabla is chasing.
The healthcare landscape is changing rapidly. Clinicians are overwhelmed. Burnout is rampant. Nabla’s AI assistant addresses these issues head-on. By cutting documentation time by more than half, it allows clinicians to focus on what truly matters: patient care. Studies from the University of Iowa Health Care and real-world data from Denver Health confirm significant reductions in clinician burnout and a notable increase in patient satisfaction.
Nabla’s growth trajectory is impressive. In just six months, the company has multiplied its revenue fivefold. It now supports over 85,000 clinicians and facilitates 20 million annual encounters. This rapid adoption is a testament to the platform's effectiveness. It’s not just about numbers; it’s about impact. The assistant is designed to serve a broad range of care environments, from rural hospitals to children’s hospitals, where operational efficiency is critical.
The upcoming features of Nabla’s Adaptive Agentic Platform are exciting. A proactive coding agent will enhance real-time support for coding practices, ensuring compliance and accuracy. A context-aware agent will leverage historical data to improve documentation and initiate orders. This is not just an upgrade; it’s a transformation. The platform is evolving into a comprehensive solution that anticipates the needs of clinicians.
Nabla’s commitment to customization is noteworthy. The platform is built to adapt to various specialties and care settings. This flexibility is crucial in a field where one size does not fit all. The company’s focus on clinician experience and enterprise readiness sets it apart. Health systems report high adoption rates and streamlined onboarding processes. Nabla listens to its partners, adapting its technology based on real-time feedback. This collaborative approach fosters trust and drives meaningful change.
The healthcare industry is at a crossroads. As technology advances, the need for intelligent solutions becomes more pressing. Nabla stands out as a pioneer in clinical AI. Its ability to combine technological excellence with empathy for clinicians is remarkable. The company is not just building a product; it’s shaping the future of healthcare.
Nabla’s journey is just beginning. With the new funding, the company is set to deepen its integration into clinical workflows. The vision is clear: a proactive assistant that enhances care delivery. This is not just about efficiency; it’s about improving the clinician-patient relationship. By reducing administrative burdens, Nabla allows healthcare providers to spend more time with their patients.
The road ahead is filled with opportunities. As Nabla expands its capabilities, it will continue to address the pressing challenges in healthcare. The focus on clinician burnout and patient satisfaction is more relevant than ever. In a world where time is a precious commodity, Nabla’s AI assistant is a beacon of hope.
In conclusion, Nabla’s $70 million funding round is more than just a financial milestone. It’s a signal of the changing tides in healthcare. The company is poised to lead the charge in transforming clinical workflows through intelligent AI solutions. As it continues to innovate, the impact on clinicians and patients alike will be profound. The future of healthcare is here, and Nabla is at the forefront.